Stay updated on Risankizumab vs Secukinumab in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe revision label on the page updated to v3.6.3, indicating a behind-the-scenes update to the platform. This change does not alter the study details or user-facing content.SummaryDifference0.0%

- Check23 days agoChange DetectedThe page footer now displays Revision: v3.6.2, replacing the previous v3.6.0.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page now indicates recruitment has closed and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also adjusts the Intervention/Treatment heading and updates the revision to v3.6.0.SummaryDifference0.3%

- Check45 days agoChange DetectedThe revision in the page footer was updated from v3.5.4 to v3.5.5, indicating a maintenance release with no changes to the study details or page behavior.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.5.4 was added and Revision: v3.5.3 was removed, indicating an updated release tag for the page's documentation assets.SummaryDifference0.0%

- Check87 days agoChange DetectedThe footer revision/version indicator on the study page has been updated from v3.5.2 to v3.5.3, reflecting a site maintenance or release update rather than a change to the clinical study content.SummaryDifference0.0%

Stay in the know with updates to Risankizumab vs Secukinumab in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.